Evaluation of a Novel Microfluidic Device for Epitope-Independent Enrichment of Circulating Tumor Cells; ANGLE’s Parsortix System

Circulating tumour cells (CTCs) have potential utility as minimally-invasive biomarkers to aid treatment decision making. Many technologies that enrich CTCs based on expression of specific epitopes may miss CTC heterogeneity; new epitope-independent methods are needed. The Parsortix system from ANGLE uses a patented micro-fluidic technology in the form of a disposable cassette to capture and then harvest circulating tumour cells (CTCs) from blood. This scientific poster evaluated the capture and harvest efficiency of the Pasortix system as well as comparing it to the CellSearch system.